Robo drugs: The future of medicine?

Programmable therapeutics, automation, and robotics – what will the next era of medicine look like?

The next generation of critical drug and vaccine development will be supercharged by advancements in automation and AI, getting breakthroughs in the lab to clinical trials faster than ever before.

“How do we take AI tools and actually innovate where biotech is today? But the future; so nucleic acids especially are just code,” said Jacob Becraft, co-founder and CEO at Strand Therapeutics.

“They’re not ones and zeros, they’re A, T, G and C. Or in the case of MRNA, they’re A, U, G and C. Since that’s just still a sort of code with four bases instead of two, you can actually train a lot of AI models in the same sort of way.”

This panel of experts across programmable therapeutics, automation, and robotics, explore what’s happening in the latest state-of-the-art labs, and discuss how automation is helping usher in a new era of medicine.

Nikhita Singh, co-founder and chief product officer at Artificial, Jacob Becraft, co-founder and CEO at Strand Therapeutics, and Victoria Sun, principal at Playground Global were in conversation with Adam Bluestein, contributing writer at Fast Company on the TalkRobot stage at Web Summit 2022.

Subscribe to 🎙️ The Next Stage 🎙️ wherever you get your podcasts, and download this episode – or listen on the embedded player above right now.

Join us in Lisbon next year for more exciting talks. Pre-register now for your Web Summit 2023 tickets.

Main image of Nikhita Singh, Co-founder & Chief Product Officer, Artificial; Jacob Becraft, Co-founder & CEO, Strand Therapeutics; Victoria Sun, Principal, Playground Global and Adam Bluestein, Contributing Writer, Fast Company: Stephen McCarthy/Web Summit ((CC BY 2.0))